Patient-Factors Influencing the 2-Year Trajectory of Mental and Physical Health in Prostate Cancer Patients.
SF-12
growth mixture model
health related quality of life
prostate cancer
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
31 10 2022
31 10 2022
Historique:
received:
06
09
2022
revised:
12
10
2022
accepted:
26
10
2022
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
This study aimed to examine the physical and mental Quality of Life (QoL) trajectories in prostate cancer (PCa) patients participating in the Pros-IT CNR study. QoL was assessed using the Physical (PCS) and Mental Component Score (MCS) of Short-Form Health Survey upon diagnosis and two years later. Growth mixture models were applied on 1158 patients and 3 trajectories over time were identified for MCS: 75% of patients had constantly high scores, 13% had permanently low scores and 12% starting with low scores had a recovery; the predictors that differentiated the trajectories were age, comorbidities, a family history of PCa, and the bowel, urinary and sexual functional scores at diagnosis. In the physical domain, 2 trajectories were defined: 85% of patients had constantly high scores, while 15% started with low scores and had a further slight decrease. Two years after diagnosis, the psychological and physical status was moderately compromised in more than 10% of PCa patients. For mental health, the trajectory analysis suggested that following the compromised patients at diagnosis until treatment could allow identification of those more vulnerable, for which a level 2 intervention with support from a non-oncology team supervised by a clinical psychologist could be of help.
Identifiants
pubmed: 36354711
pii: curroncol29110651
doi: 10.3390/curroncol29110651
pmc: PMC9689299
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8244-8260Références
Urology. 2005 Aug;66(2):338-43
pubmed: 16098363
BJU Int. 2014 Dec;114(6b):E74-E81
pubmed: 24588845
J Cancer Surviv. 2016 Apr;10(2):406-15
pubmed: 26428396
Int J Cancer. 2017 Apr 1;140(7):1517-1527
pubmed: 28006843
Int Braz J Urol. 2020 Nov-Dec;46(6):993-1005
pubmed: 32822128
BMJ Open. 2014 Mar 13;4(3):e003901
pubmed: 24625637
BMC Public Health. 2018 Aug 23;18(1):1060
pubmed: 30139347
Int J Behav Dev. 2009;33(6):565-576
pubmed: 23885133
Health Qual Life Outcomes. 2019 Jan 14;17(1):11
pubmed: 30642340
Implement Sci. 2018 Jul 26;13(1):98
pubmed: 30045735
Biopsychosoc Med. 2007 Jan 10;1:2
pubmed: 17371571
Support Care Cancer. 2021 Feb;29(2):645-651
pubmed: 32424643
Soc Sci Med. 2006 Aug;63(4):911-9
pubmed: 16798130
Clin Epidemiol. 2020 Oct 30;12:1205-1222
pubmed: 33154677
BMC Med Res Methodol. 2021 Apr 21;21(1):79
pubmed: 33882863
Eur Urol. 2017 Feb;71(2):274-280
pubmed: 27720532
Cancers (Basel). 2021 Mar 23;13(6):
pubmed: 33806994
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Control Clin Trials. 1989 Dec;10(4):407-15
pubmed: 2691207
COPD. 2005 Mar;2(1):57-62
pubmed: 17136963
Health Qual Life Outcomes. 2018 Jun 13;16(1):122
pubmed: 29898750
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):120-7
pubmed: 22212706
BMJ. 2019 Jan 25;364:l408
pubmed: 30683652
Radiother Oncol. 2013 Aug;108(2):306-13
pubmed: 23849168
BJU Int. 2016 Jun;117(6B):E10-9
pubmed: 25818406
Qual Life Res. 2016 Sep;25(9):2379-93
pubmed: 26908258
Tumori. 2015 Mar-Apr;101(2):223-31
pubmed: 25702659
N Engl J Med. 2016 Oct 13;375(15):1425-1437
pubmed: 27626365
Eur Urol. 2015 Oct;68(4):600-8
pubmed: 25242555
Br J Cancer. 2006 Apr 24;94(8):1093-8
pubmed: 16622434
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):313-318
pubmed: 28966959
BJU Int. 2011 Apr;107(8):1223-31
pubmed: 21070583
Support Care Cancer. 2018 Apr;26(4):1297-1304
pubmed: 29127529
Eur Urol. 2015 Apr;67(4):637-45
pubmed: 25454617
Aging Clin Exp Res. 2017 Apr;29(2):165-172
pubmed: 28236267
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
JAMA. 2020 Jan 14;323(2):149-163
pubmed: 31935027
Psychooncology. 2017 Oct;26(10):1576-1585
pubmed: 27943512
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
Urol Oncol. 2015 Feb;33(2):69.e19-28
pubmed: 24433753